Cargando…

P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population

Detalles Bibliográficos
Autores principales:	Rosazza, C., Medino, P., Bandera, A., Boraso, M.S., Ciciriello, F., Cipolli, M., Galietta, L.J., Gramegna, A., Itri, T., Lucidi, V., Biffi, A., Alicandro, G., Colombo, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2022
Materias:	Poster Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184776/ http://dx.doi.org/10.1016/S1569-1993(22)00387-3

Ejemplares similares

534 COVID-19 in people with cystic fibrosis and the general population: Severity and virus-host cell interactions
por: Colombo, C., et al.
Publicado: (2022)

Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
por: Medino, Paola, et al.
Publicado: (2022)

P212 Clinical and transcriptomic features of COVID-19 in cystic fibrosis: a prospective multi-centre study
por: Ciciriello, F., et al.
Publicado: (2023)

Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups
por: Rosazza, Chiara, et al.
Publicado: (2023)

ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2022)

Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022)

Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2023)

Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
por: Colombo, Carla, et al.
Publicado: (2021)

532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Daccò, V., et al.
Publicado: (2022)

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
por: Scudieri, Paolo, et al.
Publicado: (2020)

Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosis
por: Battezzati, Alberto, et al.
Publicado: (2022)

P175 Extended incubation of cystic fibrosis cultures: is it worth it?
por: Amado, R., et al.
Publicado: (2019)

P074 Post-COVID-19 condition in children with cystic fibrosis
por: Chernyavskaya, A., et al.
Publicado: (2022)

Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study
por: Foppiani, Andrea, et al.
Publicado: (2023)

P075 COVID-19 vaccination uptake in patients with cystic fibrosis
por: Manning, D.-E., et al.
Publicado: (2022)

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
por: Montemari, Anna Lisa, et al.
Publicado: (2022)

WS07.06 CFTR impacts SARS-CoV-2 infection in cystic fibrosis
por: Bragonzi, A., et al.
Publicado: (2023)

P077 Vaccination of patients with cystic fibrosis during the COVID-19 pandemic in Croatia
por: Markelić, I., et al.
Publicado: (2022)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
por: Colombo, C., et al.
Publicado: (2021)

Breastfeeding in Cystic Fibrosis: A Systematic Review on Prevalence and Potential Benefits
por: Colombo, Carla, et al.
Publicado: (2021)

ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia
por: Bambir, I., et al.
Publicado: (2022)

P078 Adverse effects of Kaftrio® in an adult cystic fibrosis clinic
por: McCabe, D.
Publicado: (2022)

A successful treatment of a lobar atelectasis in a patient with cystic fibrosis
por: Daccò, Valeria, et al.
Publicado: (2022)

Is cellular senescence involved in cystic fibrosis?
por: Bezzerri, Valentino, et al.
Publicado: (2019)

Poster Sessions 054-249
Publicado: (2004)

P076 COVID-19 vaccination in children and adolescents with cystic fibrosis - a single-centre experience
por: Zver, A., et al.
Publicado: (2022)

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes
por: Grancini, V., et al.
Publicado: (2023)

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
por: Colombo, Carla, et al.
Publicado: (2021)

Does cystic fibrosis constitute an advantage in COVID-19 infection?
por: Bezzerri, Valentino, et al.
Publicado: (2020)

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience
por: Vidoevska, A., et al.
Publicado: (2022)

ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK
por: Lau, D., et al.
Publicado: (2022)

EPS2.04 The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre, UK
por: Connolly, A., et al.
Publicado: (2021)

Opération piquet PO 2000-054
por: Royer, J P
Publicado: (2000)

ePS1.05 Impact of COVID-19 on mental health among people with cystic fibrosis
por: Chrysochoou, E.-A., et al.
Publicado: (2022)

WS20.06 Co-infection with Nocardia farcinia and SARS-CoV-2 causing the death of an adolescent with cystic fibrosis
por: Chapman, J., et al.
Publicado: (2022)

P073 Observed impact on admissions during the COVID-19 pandemic of paediatric cystic fibrosis patients in a tertiary hospital setting
por: Warraich, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_846qcr2r243l3025tvlcuilhri